2008DMW - Deutsche Medizinische WochenschriftRequires access

Medikamentenresistente Malaria in Ostafrika

Axel Kroeger, H. J. Diesfeld

Open publisher page 4 citations

Abstract

Two tourists from Kenya with falciparum malaria had an R1-resistance against chloroquine (WHO-extended field test, no in-vitro test). In addition, one of them was resistant against pyrimethamine-sulfadoxine (Fansidar), however sensitive against quinine and mefloquine. In a third tourist, from Tanzania, a diagnosis of chloroquine-resistance had been made too early and drug medication had been changed. These observations document the necessity of early species diagnosis. It is recommended to consider also in patients from East Africa the possibility of multiple resistances of falciparum malaria and to change medication if required.

About this research paper

What this paper is about

Two tourists from Kenya with falciparum malaria had an R1-resistance against chloroquine (WHO-extended field test, no in-vitro test). In addition, one of them was resistant against pyrimethamine-sulfadoxine (Fansidar), however sensitive against quinine and mefloquine. In a third tourist, from Tanzania, a diagnosis of chloroquine-resistance had been made too early and drug medication had been changed. These observations document the necessity of early species diagnosis. It is recommended to consider also in patients from East Africa the possibility of multiple resistances of falciparum malaria and to change medication if required.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Two tourists from Kenya with falciparum malaria had an R1-resistance against chloroquine (WHO-extended field test, no in-vitro test). In addition, one of them was resistant against pyrimethamine-sulfadoxine (Fansidar), however sensitive against quinine and mefloquine. In a third tourist, from Tanzania, a diagnosis of chloroquine-resistance had been made too early and drug medication had been changed. These observations document the necessity of early species diagnosis. It is recommended to consider also in patients from East Africa the possibility of multiple resistances of falciparum malaria and to change medication if required.

Key concepts: Mefloquine, Malaria, Chloroquine, Tanzania, Quinine, Sulfadoxine, Pyrimethamine, Plasmodium falciparum

Related papers

Back to paper searchBrowse research topicsOriginal source
Medikamentenresistente Malaria in Ostafrika — Research Paper | ScholarLens